Ogsiveo 150 mg, Filmtabletten

7680703890028 CH-70389 Filmtabletten

No image available

Article details

Package size
56
Selling units
56
Measure
Tablette(n)
Galenic form
Filmtabletten
Galenic group
Tabletten

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
17/09/2026
Patient information leaflet
Français
17/09/2026
Patient information leaflet
Italien
17/09/2026
Summary of Product Characteristics
Allemand
17/09/2026
Summary of Product Characteristics
Français
17/09/2026
Summary of Product Characteristics
Italien
17/09/2026

Detailed composition

Substance Quantity Type Category
nirogacestatum
150.0 MG Substance Wirkstoff (Principe actif)
nirogacestatum dihydrobromidum
199.574 MG Substance WIZUS
cellulosum microcristallinum
- Substance HNIDK
lactosum monohydricum
173.475 MG Substance HBESI
natrium
- Substance HBESI
magnesii stearas
- Substance HNIDK
copolymerum macrogolo et alcoholi poly(vinylico) constatum
- Substance HNIDK
talcum
- Substance HNIDK
E 171
- Substance FNIDK
glyceroli mono/dicaprylocapras
- Substance HNIDK
poly(alcohol vinylicus)
- Substance HNIDK
E 110
0.135 MG Substance FIMDK
E 172 (flavum)
- Substance FTODK

Authorization holder

Merck (Schweiz) AG

6300 Zug

Authorization information

Swissmedic authorization number
70389
Drug name
Ogsiveo, Filmtabletten
Galenic form
FILM
ATC Code
L01XX81
Authorization status
Z
Dispensing category
A
First authorization
19/05/2026
Authorization expiration date
18/05/2031
IT Number
07.16.1.
Domain
Human medicine
Field of application
Progressive desmoide Tumore

Package details

Description (FR)
OGSIVEO cpr pellic 150 mg 56 pce
Description (DE)
OGSIVEO Filmtabl 150 mg 56 Stk
Market launch
15/06/2026
Narcotic (BTM)
No

Other package sizes (1)

OGSIVEO cpr pellic 100 mg 56 pce
56 TABL
GTIN: 7680703890011
View
Buy us a coffee Explore the data